-
Optimized Cell Proliferation with Cell Counting Kit-8 (CCK-8
2026-07-03
Cell Counting Kit-8 (CCK-8) Plus addresses the need for rapid, sensitive, and reproducible cell viability and cytotoxicity assays in modern research. It is particularly effective for routine cell proliferation, cytotoxicity, and drug screening studies, but should be avoided in systems where metabolic interference or non-reducing cell types could confound results.
-
Olaparib (AZD2281): Mechanisms and Benchmarks in Cancer Rese
2026-07-03
Olaparib (AZD2281, Ku-0059436) is a potent, selective PARP-1/2 inhibitor essential for DNA damage response and BRCA-associated cancer targeted therapy. Its efficacy in impairing DNA repair is supported by strong in vitro and in vivo evidence, enabling its integration in tumor radiosensitization studies and combinatorial cancer research protocols.
-
LC–MS/MS Analysis of Novel GS-441524 Prodrug Conversion Path
2026-07-02
This study introduces a novel GS-441524 prodrug (NGP-1) engineered to enhance oral bioavailability and anti-SARS-CoV-2 activity. Utilizing a new LC–MS/MS approach, the research clarifies in vitro and in vivo conversion dynamics, providing foundational insights for pharmacokinetic optimization and future clinical translation.
-
Bismuth Subsalicylate in GI Disorder Research: Protocols & I
2026-07-02
Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) empowers researchers to dissect gastrointestinal inflammation and apoptosis with reproducible, high-purity workflow performance. Explore how APExBIO’s formulation streamlines assay design, optimizes detection of membrane changes, and supports robust troubleshooting for translational studies.
-
Precision Proliferation Analysis: EdU Flow Cytometry in TNBC
2026-07-01
Explore the intersection of ferroptosis, cell cycle regulation, and translational oncology with a focus on EdU Flow Cytometry Assay Kits (Cy3). This article provides mechanistic insight into triple-negative breast cancer (TNBC) proliferation, strategic guidance for leveraging advanced DNA synthesis detection, and a critical comparison to legacy methods. Drawing on recent research and best practices, it offers actionable recommendations for translational researchers aiming to dissect tumor cell dynamics with precision and efficiency.
-
Etoposide (VP-16): Precision DNA Damage & Apoptosis Research
2026-07-01
Etoposide (VP-16) is a gold-standard topoisomerase II inhibitor, enabling precise DNA damage and apoptosis induction in cancer research. This guide details advanced experimental workflows, troubleshooting strategies, and practical insights for maximizing reproducibility and data quality with APExBIO’s Etoposide.
-
Ro 3306: Advanced CDK1 Inhibitor for G2/M Cell Cycle Control
2026-06-30
Ro 3306 empowers researchers with precise, reversible G2/M phase arrest and robust cancer cell synchronization for DNA repair and cell cycle checkpoint studies. By leveraging new insights into mTORC1 oscillations, this CDK1 inhibitor defines cutting-edge workflows for dissecting mitotic entry and homologous recombination inhibition.
-
CCG-1423: A Precision RhoA Inhibitor for Cancer and Virology
2026-06-30
CCG-1423 delivers targeted RhoA/ROCK signaling inhibition, empowering researchers to dissect processes from cancer invasion to viral entry with unprecedented specificity. APExBIO's high-purity formulation supports reliable workflows for cell signaling, apoptosis, and tight junction dynamics.
-
Distinct Mechanisms of Chuanxiong Cortex Compounds in CHD Th
2026-06-29
This study utilizes advanced SPME-GC×GC-MS and network pharmacology to reveal the differential bioactive profiles and mechanisms of Ligusticum chuanxiong cortex and pith in coronary heart disease (CHD). It identifies Fenipentol as a key cortex-derived modulator, offering new insights for cardiovascular and gastrointestinal research.
-
Optimized Expression and Kinetic Analysis of M. tuberculosis
2026-06-29
This study details a robust approach for the over-expression, purification, and kinetic characterization of the integral membrane enzyme WecA from Mycobacterium tuberculosis. The methodological advances enable detailed functional studies of WecA, a high-value drug target for tuberculosis therapy.
-
CRTC-CREB Axis Senses Proteotoxic Stress via Proteasome Inhi
2026-06-28
This study reveals that proteasome inhibitors, including MLN2238, robustly activate the conserved CRTC-CREB transcriptional axis in Drosophila, linking proteasome inhibition to ROS/JNK signaling and adaptive transcriptional responses. The findings provide mechanistic insight into how cells sense and mitigate proteotoxic stress, with implications for neurodegenerative and aging research.
-
Apigenin for HDAC Inhibition: Protocols in Oncology & Neurop
2026-06-27
Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) unlocks precise control of epigenetic and neuroinflammatory pathways in malignant mesothelioma and Alzheimer’s disease models. This guide bridges network pharmacology and bench protocols, providing actionable parameters, troubleshooting tips, and unique translational insight for cancer and neurodegeneration researchers.
-
GW4064: Non-Steroidal FXR Agonist for Advanced Metabolic Res
2026-06-26
GW4064 empowers researchers to dissect FXR signaling with precision, driving breakthroughs in metabolic and fibrosis models. Applied best-practices and troubleshooting insights unlock reproducible, high-fidelity results for advanced lipid and bile acid pathway studies.
-
Mitochondrial Calcium Suppresses Ferroptosis via GPX4 Acetyl
2026-06-26
This study reveals how mitochondrial calcium uptake, regulated by the MCU, protects against ferroptotic cell death by promoting acetylation of GPX4, a central ferroptosis repressor. These findings clarify the metabolic-epigenetic link in ferroptosis control and suggest new directions for targeted ferroptosis inhibition in disease models.
-
nor-Binaltorphimine Dihydrochloride: Dissecting Opioid Recep
2026-06-25
Explore how nor-Binaltorphimine dihydrochloride, a selective κ-opioid receptor antagonist, empowers researchers to unravel discrete brain-spinal opioid circuits in mechanical pain hypersensitivity and tolerance. This in-depth analysis delivers scientific clarity and practical assay guidance beyond existing resources.